by John Conrad | Mar 31, 2020 | COVID, Member News
BioLife Plasma Services, part of Takeda, has implemented a unique protocol for collecting plasma from healthy individuals who have recovered from COVID-19 to enable development of a potential therapy for COVID-19, made from human plasma. You can read more about this...
by John Conrad | Mar 30, 2020 | Member News
The AIM-HI Accelerator Fund, a venture philanthropy organization created in 2019 with support from the National Foundation for Cancer Research, will conduct its 2020 Women’s Venture Competition later this year in Boston—originally scheduled for May 20 but potentially...
by John Conrad | Mar 30, 2020 | COVID, Member News
Medtronic is publicly sharing the designs for one of its ventilator models to help people across the world to devise options for rapid ventilator manufacturing. The move is designed to help doctors and patients combat the impact of Covid-19. The Puritan Bennet 560 has...
by John Conrad | Mar 26, 2020 | COVID, Member News
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it, in partnership with IllinoisGovernor JB Pritzker, has provided $500,000 to the Illinois COVID-19 Response Fund and $500,000 to the Illinois Biotechnology Innovation Organization (iBIO) Institute’s...
by John Conrad | Mar 20, 2020 | COVID, Member News
Originally posted on CSL Behring’s WebsiteOriginally posted on CSL Behring’s Website As coronavirus (COVID-19) cases mount, global biotech leader CSL has formally offered to help governments around the world by lending its expertise, technologies and facilities to...
by John Conrad | Mar 19, 2020 | COVID, Member News
Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company’s molecular test for novel coronavirus (COVID-19). Abbott is immediately shipping 150,000 Abbott RealTime SARS-CoV-2 EUA...
